Peregrine Pharmaceuticals | Eiendeler

Assets Endring Dato
AstraZeneca USD 96.09B 457M 2023-09
Celldex Therapeutics USD 465.63M 185.37M 2023-12
MannKind USD 475.2M 154.87M 2023-12
Roche Holding CHF 84.37B 3.78B 2023-06
Xencor USD 952.69M 174.26M 2023-12



Peregrine Pharmaceuticals Eiendeler - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - May 2024.